Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Postmarketing study of Vaqta supports safety of hepatitis A vaccine

Sep. 24, 1998

HemispheRx broadens hepatitis C portfolio

Sep. 24, 1998

FDA will give priority review to Nabi's reformulated H-BIG

Sep. 23, 1998

Fucoidan from seaweed extract shows antiulcer activity in preclinical models

Sep. 23, 1998

New target for treating HCV infection: NS3-4A proteinase

Sep. 22, 1998

AxyS Pharmaceuticals reaches milestone in Bristol-Myers Squibb collaboration

Sep. 22, 1998

Novel antiulcer agent effectively reduces gastric bleeding and lesion formation in rats

Sep. 22, 1998

Phase IIb trial results confirm efficacy and safety of INKP-100 for colonoscopy

Sep. 21, 1998

Pylorid-containing triple therapy effective in eradicating H. pylori

Sep. 16, 1998

Early clinical trial results reported for cilansetron at recent congress

Sep. 14, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...